PURPOSE: Identification of demographic, physical/physiological, lifestyle and genetic factors contributing to the onset of dementia, specifically Alzheimer disease (AD), and implementation of novel methods for early diagnosis are important to alleviate prevalence of dementia globally. The Czech Brain Aging Study (CBAS) is the first large, prospective study to address these issues in Central/Eastern Europe by enrolling non-demented adults aged 55+ years, collecting a variety of personal and biological measures and tracking cognitive function over time. PARTICIPANTS: The CBAS recruitment was initiated in 2011 from memory clinics at Brno and Prague University Hospitals, and by the end of 2018, the study included 1228 participants. Annual follow-ups include collection of socioeconomic, lifestyle and personal history information, neurology, neuropsychology, laboratory, vital sign and brain MRI data. In a subset, biomarker assessment (cerebrospinal fluid (CSF) and amyloid positron emission tomography) and spatial navigation were performed. Participants were 69.7±8.1 years old and had 14.6±3.3 years of education at baseline, and 59% were women. By the end of 2018, 31% finished three and more years of follow-up; 9% converted to dementia. Apolipoprotein E status is available from 95% of the participants. The biological sample bank linked to CBAS database contained CSF, serum and DNA. FINDINGS TO DATE: Overall, the findings, mainly from cross-sectional analyses, indicate that spatial navigation is a promising marker of early AD and that it can be distinguished from other cognitive functions. Specificity of several standard memory tests for early AD pathology was assessed with implications for clinical practice. The relationship of various lifestyle factors to cognition and brain atrophy was reported. FUTURE PLANS: Recruitment is ongoing with secured funding. Longitudinal data analyses are currently being conducted. Proposals for collaboration on specific data from the database or biospecimen, as well as collaborations with similar cohort studies to increase sample size, are welcome. Study details are available online (www.cbas.cz).

International Clinical Research Center St Anne's University Hospital Brno Czech Republic

Memory Clinic Department of Neurology Motol University Hospital Prague Czech Republic

Neurology Department St Anne's University Hospital Brno Czech Republic

School of Aging Studies University of South Florida Tampa Florida USA

Zobrazit více v PubMed

Jorm AF, Korten AE, Henderson AS. The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatr Scand 1987;76:465–79. 10.1111/j.1600-0447.1987.tb02906.x PubMed DOI

Kukull WA, Ganguli M. Epidemiology of dementia: concepts and overview. Neurol Clin 2000;18:923–50. 10.1016/s0733-8619(05)70233-4 PubMed DOI

Matthews FE, Arthur A, Barnes LE, et al. . A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the cognitive function and ageing study I and II. Lancet 2013;382:1405–12. 10.1016/S0140-6736(13)61570-6 PubMed DOI PMC

Qiu C, von Strauss E, Bäckman L, et al. . Twenty-year changes in dementia occurrence suggest decreasing incidence in central Stockholm, Sweden. Neurology 2013;80:1888–94. 10.1212/WNL.0b013e318292a2f9 PubMed DOI

Cífková R, Skodová Z. [Longitudinal trends in major cardiovascular disease risk factors in the Czech population]. Cas Lek Cesk 2004;143:219–26. PubMed

Pająk A, Kozela M. Cardiovascular disease in central and East Europe. Public Health Rev 2011;33:416–35. 10.1007/BF03391644 DOI

Sheardova K, Hort J, Rektorova I, et al. . Dementia diagnosis and treatment in Czech neurological and psychiatric practices. Cesk Slov Neurol N 2012;75:208–11.

Albert MS, DeKosky ST, Dickson D, et al. . The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011;7:270–9. 10.1016/j.jalz.2011.03.008 PubMed DOI PMC

Sorbi S, Hort J, Erkinjuntti T, et al. . EFNS-ENS guidelines on the diagnosis and management of disorders associated with dementia. Eur J Neurol 2012;19:1159–79. 10.1111/j.1468-1331.2012.03784.x PubMed DOI

Weintraub S, Salmon D, Mercaldo N, et al. . The Alzheimer's disease centers' uniform data set (UDS): the neuropsychologic test battery. Alzheimer Dis Assoc Disord 2009;23:91–101. 10.1097/WAD.0b013e318191c7dd PubMed DOI PMC

Nikolai T, Stepankova H, Kopecek M, et al. . The uniform data set, Czech version: normative data in older adults from an international perspective. J Alzheimers Dis 2018;61:1233–40. 10.3233/JAD-170595 PubMed DOI PMC

Desikan RS, Ségonne F, Fischl B, et al. . An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage 2006;31:968–80. 10.1016/j.neuroimage.2006.01.021 PubMed DOI

Fischl B, Salat DH, Busa E, et al. . Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 2002;33:341–55. 10.1016/s0896-6273(02)00569-x PubMed DOI

Reuter M, Schmansky NJ, Rosas HD, et al. . Within-subject template estimation for unbiased longitudinal image analysis. Neuroimage 2012;61:1402–18. 10.1016/j.neuroimage.2012.02.084 PubMed DOI PMC

Nedelska Z, Andel R, Laczó J, et al. . Spatial navigation impairment is proportional to right hippocampal volume. Proc Natl Acad Sci U S A 2012;109:2590–4. 10.1073/pnas.1121588109 PubMed DOI PMC

Horínek D, Petrovický P, Hort J, et al. . Amygdalar volume and psychiatric symptoms in Alzheimer's disease: an MRI analysis. Acta Neurol Scand 2006;113:40–5. 10.1111/j.1600-0404.2006.00540.x PubMed DOI

Kerbler GM, Nedelska Z, Fripp J, et al. . Basal forebrain atrophy contributes to allocentric navigation impairment in Alzheimer's disease patients. Front Aging Neurosci 2015;7:185 10.3389/fnagi.2015.00185 PubMed DOI PMC

Vanderstichele H, Bibl M, Engelborghs S, et al. . Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's biomarkers standardization initiative. Alzheimers Dement 2012;8:65–73. 10.1016/j.jalz.2011.07.004 PubMed DOI

Hort J, Glosova L, Vyhnalek M, et al. . The liquor tau protein and beta amylold in Alzheimer's disease. Cesk Slov Neurol N 2007;70:30–6.

Sheardova K, Laczó J, Vyhnalek M, et al. . Famous landmark identification in amnestic mild cognitive impairment and Alzheimer's disease. PLoS One 2014;9:e105623 10.1371/journal.pone.0105623 PubMed DOI PMC

Cerman J, Andel R, Laczo J, et al. . Subjective spatial navigation complaints - a frequent symptom reported by patients with subjective cognitive decline, mild cognitive impairment and alzheimer's disease. Curr Alzheimer Res 2018;15:219–28. 10.2174/1567205014666171120145349 PubMed DOI

Hort J, Laczó J, Vyhnálek M, et al. . Spatial navigation deficit in amnestic mild cognitive impairment. Proc Natl Acad Sci U S A 2007;104:4042–7. 10.1073/pnas.0611314104 PubMed DOI PMC

Laczó J, Vlček K, Vyhnálek M, et al. . Spatial navigation testing discriminates two types of amnestic mild cognitive impairment. Behav Brain Res 2009;202:252–9. 10.1016/j.bbr.2009.03.041 PubMed DOI

Parizkova M, Lerch O, Moffat SD, et al. . The effect of Alzheimer's disease on spatial navigation strategies. Neurobiol Aging 2018;64:107–15. 10.1016/j.neurobiolaging.2017.12.019 PubMed DOI

Mokrisova I, Laczo J, Andel R, et al. . Real-space path integration is impaired in Alzheimer's disease and mild cognitive impairment. Behav Brain Res 2016;307:150–8. 10.1016/j.bbr.2016.03.052 PubMed DOI

Laczó J, Andel R, Nedelska Z, et al. . Exploring the contribution of spatial navigation to cognitive functioning in older adults. Neurobiol Aging 2017;51:67–70. 10.1016/j.neurobiolaging.2016.12.003 PubMed DOI

Laczó J, Andel R, Vyhnalek M, et al. . From Morris water maze to computer tests in the prediction of Alzheimer's disease. Neurodegener Dis 2012;10:153–7. 10.1159/000333121 PubMed DOI

Hort J, Andel R, Mokrisova I, et al. . Effect of donepezil in Alzheimer disease can be measured by a computerized human analog of the Morris water maze. Neurodegener Dis 2014;13:192–6. 10.1159/000355517 PubMed DOI

YF W, WB W, Liu QP, et al. . Presence of lacunar infarctions is associated with the spatial navigation impairment in patients with mild cognitive impairment: a DTI study. Oncotarget 2016;7:78310–9. PubMed PMC

Cerman J, Laczó J, Vyhnalek M, et al. . Differences in spatial navigation impairment in neurodegenerative dementias. Cesk Slov Neurol 2014;77:449–55.

Laczó J, Andel R, Vyhnalek M, et al. . APOE and spatial navigation in amnestic MCI: results from a computer-based test. Neuropsychology 2014;28:676–84. 10.1037/neu0000072 PubMed DOI

Laczó J, Andel R, Vyhnalek M, et al. . The effect of TOMM40 on spatial navigation in amnestic mild cognitive impairment. Neurobiol Aging 2015;36:2024–33. 10.1016/j.neurobiolaging.2015.03.004 PubMed DOI

Pařízková M, Andel R, Lerch O, et al. . Homocysteine and real-space navigation performance among non-demented older adults. J Alzheimers Dis 2017;55:951–64. 10.3233/JAD-160667 PubMed DOI

Vyhnalek M, Nikolai T, Andel R, et al. . Neuropsychological correlates of hippocampal atrophy in memory testing in nondemented older adults. J Alzheimers Dis 2014;42 Suppl 3:S81–90. 10.3233/JAD-132642 PubMed DOI

Sheardova K, Nedelska Z, Sumec R, et al. . The effect of spiritual well-being (transcendental and non-transcendental domain) on regional brain atrophy in non-demented subjects with memory complaints: 3-year follow up data from the Czech brain aging study. Alzheimer's & Dementia 2018;14:P587–8. 10.1016/j.jalz.2018.06.654 DOI

Chanti-Ketterl M, Andel R, Lerch O, et al. . Cholesterol and cognitive performance among community volunteers from the Czech Republic. Int Psychogeriatr 2015;27:2087–95. 10.1017/S1041610215000320 PubMed DOI

Pappas C, Small BJ, Andel R, et al. . Blood glucose levels may exacerbate executive function deficits in older adults with cognitive impairment. J Alzheimers Dis 2019;67:81–9. 10.3233/JAD-180693 PubMed DOI

Sumec R, Sheardova K, Marciniak R, et al. . Meditation's impact on cognitive functions in mild cognitive impairment: a pilot study. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2017;161:54–6. PubMed

Tillmann T, Pikhart H, Peasey A, et al. . Psychosocial and socioeconomic determinants of cardiovascular mortality in eastern Europe: a multicentre prospective cohort study. PLoS Med 2017;14:e1002459 10.1371/journal.pmed.1002459 PubMed DOI PMC

Brayne C, Davis D. Making Alzheimer's and dementia research fit for populations. Lancet 2012;380:1441–3. 10.1016/S0140-6736(12)61803-0 PubMed DOI PMC

Sachdev PS, Lipnicki DM, Kochan NA, et al. . The prevalence of mild cognitive impairment in diverse geographical and Ethnocultural regions: the COSMIC collaboration. PLoS One 2015;10:e0142388 10.1371/journal.pone.0142388 PubMed DOI PMC

Yesavage JA, Brink TL, Rose TL, et al. . Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 1982;17:37–49. 10.1016/0022-3956(82)90033-4 PubMed DOI

Nelson HE. The National adult reading test (NART): test manual. Windsor: NFER-Nelson, 1982.

Topinkova E, Jirak R, Kozeny J. Krátká neurokognitivní baterie pro screening demence V klinické praxi: sedmiminutový screeningový test. Neurol pro Praxi 2002;6:323–8.

Bezdicek O, Stepankova H, Moták L, et al. . Czech version of Rey auditory verbal learning test: normative data. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn 2014;21:693–721. 10.1080/13825585.2013.865699 PubMed DOI

Benedict RHB, Schretlen D, Groninger L, et al. . Revision of the brief visuospatial memory test: studies of normal performance, reliability, and validity. Psychol Assess 1996;8:145–53. 10.1037/1040-3590.8.2.145 DOI

Meyers JE, Meyers KR. Rey complex figure test and recognition trial: professional manual. Odessa, FL: Psychological Assessment Resources, 1995.

Bezdicek O, Lukavsky J, Stepankova H, et al. . The Prague Stroop test: normative standards in older Czech adults and discriminative validity for mild cognitive impairment in Parkinson's disease. J Clin Exp Neuropsychol 2015;37:794–807. 10.1080/13803395.2015.1057106 PubMed DOI

Wechsler D. WAIS-III - Wechslerova inteligenční škála pro dospělé. Praha: Hogrefe–Testcentrum, 2010.

Loonstra AS, Tarlow AR, Sellers AH. COWAT metanorms across age, education, and gender. Appl Neuropsychol 2001;8:161–6. 10.1207/S15324826AN0803_5 PubMed DOI

Mazancova AF, Nikolai T, Stepankova H, et al. . The reliability of clock drawing test scoring systems modeled on the normative data in healthy aging and nonamnestic mild cognitive impairment. Assessment 2017;24:945–57. 10.1177/1073191116632586 PubMed DOI

Morris JC. The clinical dementia rating (CDR): current version and scoring rules. Neurology 1993;43:2412–4. 10.1212/WNL.43.11.2412-a PubMed DOI

Pfeffer RI, Kurosaki TT, Harrah CH, et al. . Measurement of functional activities in older adults in the community. J Gerontol 1982;37:323–9. 10.1093/geronj/37.3.323 PubMed DOI

Beck AT, Epstein N, Brown G, et al. . An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 1988;56:893–7. 10.1037/0022-006X.56.6.893 PubMed DOI

Thomas-Antérion C, Ribas C, Honoré-Masson S, et al. . Le questionnaire de plainte mnésique (QPC): un outil de recherche de plainte suspecte d’évoquer une maladie d’Alzheimer. L’Année Gérontologique 2003;17:56–65.

Baecke JA, Burema J, Frijters JE. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 1982;36:936–42. 10.1093/ajcn/36.5.936 PubMed DOI

Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991;14:540–5. 10.1093/sleep/14.6.540 PubMed DOI

Reguli Z, Svobodová L. Czech version of the diagnosis of fear of falls in seniors - FES-I (Falls Efcacy Scale International). Studia Sportiva 2011;5:5–12.

Varjassyová A, Hořínek D, Andel R, et al. . Recognition of facial emotional expression in amnestic mild cognitive impairment. J Alzheimers Dis 2013;33:273–80. 10.3233/JAD-2012-120148 PubMed DOI PMC

Keane J, Calder AJ, Hodges JR, et al. . Face and emotion processing in frontal variant frontotemporal dementia. Neuropsychologia 2002;40:655–65. 10.1016/S0028-3932(01)00156-7 PubMed DOI

Papp KV, Amariglio RE, Dekhtyar M, et al. . Development of a psychometrically equivalent short form of the Face-Name associative memory exam for use along the early Alzheimer's disease trajectory. Clin Neuropsychol 2014;28:771–85. 10.1080/13854046.2014.911351 PubMed DOI PMC

Buschke H, Mowrey WB, Ramratan WS, et al. . Memory binding test distinguishes amnestic mild cognitive impairment and dementia from cognitively normal elderly. Arch Clin Neuropsychol 2017;32:29–39. 10.1093/arclin/acw083 PubMed DOI PMC

Holden HM, Hoebel C, Loftis K, et al. . Spatial pattern separation in cognitively normal young and older adults. Hippocampus 2012;22:1826–32. 10.1002/hipo.22017 PubMed DOI PMC

Vlcek K, Laczó J, Vajnerová O, et al. . Spatial navigation and episodic-memory tests in screening of dementia. Psychiatrie 2006;10:35–8.

Marková H, Laczó J, Andel R, et al. . Perspective taking abilities in amnestic mild cognitive impairment and Alzheimer's disease. Behav Brain Res 2015;281:229–38. 10.1016/j.bbr.2014.12.033 PubMed DOI

Gomez R, Fisher JW. Domains of spiritual well-being and development and validation of the spiritual well-being questionnaire. Pers Individ Dif 2003;35:1975–91. 10.1016/S0191-8869(03)00045-X DOI

OPD Working Group Operationalized Psychodynamic diagnostics: foundations and manual. Hogrefe & Huber Pub, 2001.

Evaluation of Differential Diagnostics Potential of Uniform Data Set 2 Neuropsychology Battery Using Alzheimer's Disease Biomarkers

CSF neurogranin levels as a biomarker in Alzheimer's disease and frontotemporal lobar degeneration: a cross-sectional analysis

Spatial navigation questionnaires as a supportive diagnostic tool in early Alzheimer's disease

Plasminogen activator inhibitor-1 serum levels in frontotemporal lobar degeneration

Mild behavioral impairment in early Alzheimer's disease and its association with APOE and BDNF risk genetic polymorphisms

Serum PAI-1/BDNF Ratio Is Increased in Alzheimer's Disease and Correlates with Disease Severity

Pathogenesis of Alzheimer's disease: Involvement of the choroid plexus

Cognitive reserve, neuropathology, and progression towards Alzheimer's disease

Moderating effect of cognitive reserve on brain integrity and cognitive performance

Contribution of Memory Tests to Early Identification of Conversion from Amnestic Mild Cognitive Impairment to Dementia

Alzheimer's Disease Severity Is Associated with an Imbalance in Serum Levels of Enzymes Regulating Plasmin Synthesis

The protective gene dose effect of the APOE ε2 allele on gray matter volume in cognitively unimpaired individuals

Six genetically linked mutations in the CD36 gene significantly delay the onset of Alzheimer's disease

Different Profiles of Spatial Navigation Deficits In Alzheimer's Disease Biomarker-Positive Versus Biomarker-Negative Older Adults With Amnestic Mild Cognitive Impairment

Emotional prosody recognition is impaired in Alzheimer's disease

Spatial Pattern Separation Testing Differentiates Alzheimer's Disease Biomarker-Positive and Biomarker-Negative Older Adults With Amnestic Mild Cognitive Impairment

Spatial Navigation and Visuospatial Strategies in Typical and Atypical Aging

Mild Behavioral Impairment Is Associated With Atrophy of Entorhinal Cortex and Hippocampus in a Memory Clinic Cohort

The Combined Effect of APOE and BDNF Val66Met Polymorphisms on Spatial Navigation in Older Adults

The Effect of Mindfulness-Based Stress Reduction (MBSR) on Depression, Cognition, and Immunity in Mild Cognitive Impairment: A Pilot Feasibility Study